Recognized as One of America’s Fastest-Growing Private Companies, Vaniam Group Ranks Within the Inc. 5000 for Fourth Consecutive Year
This marks the fourth consecutive year that Vaniam Group has qualified for this prestigious honor.
News
Menu
Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Young Investigator Awards
Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award and Tafadzwa L. Chaunzwa, MD, MHS, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers
Vaniam Group Appoints Robert L. Coleman as Company’s Inaugural Chief Medical Officer
With 3 decades as a leading gynecologic oncologist, Dr. Coleman’s appointment reinforces Vaniam Group’s commitment to scientific excellence and advancing patient care.
Bio Ascend, a Vaniam Group Company, Unveils Inaugural Class of the “Academy of Next Wave of Investigators™” in CLL and NHL
Nineteen early-career clinical investigators to receive year-long mentorship and professional development program led by international thought leaders.
Vaniam Group Hires Paula Franson to Lead Clinical Strategy & Solutions
Ms. Franson will help biopharma clients design a phased approach to inform and execute clinical development plans, amplify awareness within clinician and patient communities, and form partnerships necessary to accelerate clinical trial completion.
Jennifer Buffington Herzog Named President of Vaniam Group
After 8 years in leadership roles at Vaniam Group, Herzog’s appointment demonstrates agency’s continued focus on client service, operational excellence, and healthy growth.
Women Leaders in Oncology® Presents Dr Susan Scott the 2022 WLO “Women Who Conquer Cancer” Young Investigator Award
At 9th annual WLO reception, Vaniam Group makes progress on $1.35 million endowment pledge, expands WLO to be a year-round community supporting female contributions in the field of oncology.
Vaniam Group Announces Chijioke Nze, MD, MPH, as the 2022 Recipient of Conquer Cancer-Vaniam Group LLC Young Investigator Award
Dr Nze Is Second Annual Recipient of Grant Dedicated to Black, African, or African American Cancer Researchers; Will Research Barriers to Minority Participation in Lymphoma Clinical Trials.
Vaniam Group Named to Inc. Magazine’s Annual List of Best Workplaces for Second Consecutive Year
Based on 2022 employee survey data, Vaniam Group scored among top 20 US health companies.
Vaniam Group Ranks Among The Fastest-Growing Private Companies In America According To Inc. 5000 2021 Annual Ranking
Vaniam Group Receives Recognition for Second Consecutive Year.
